Literature DB >> 6531756

The calibration of the second primary international reference preparation for thromboplastin (thromboplastin, human, plain, coded BCT/253).

J M Thomson, J A Tomenson, L Poller.   

Abstract

An international collaborative exercise has been undertaken to calibrate a replacement for the first WHO primary international reference preparation (IRP) for thromboplastin. The replacement preparation is a lyophilised batch of British Comparative Thromboplastin (BCT/253, human plain) for use in the Quick prothrombin time test. Seventeen centres participated. The experimental design, calibration model and statistical analysis were based on the recommended WHO procedure. As a result of this calibration exercise an International Sensitivity Index (ISI) of 1.1 has been assigned to the preparation by WHO and it has been officially recognised as the second primary IRP for thromboplastin. The calibration of BCT/253 is an essential link in a new hierarchical structure for the standardisation of the prothrombin time. The aim is to provide a uniform international system of reporting prothrombin time results using International Normalised Ratios (INR) derived from the ISI of individual thromboplastins.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6531756

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  Laboratory control of oral anticoagulants.

Authors:  L Poller
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-09

2.  ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control. International Committee for Standardization in Haematology/International Committee on Thrombosis and Haemostasis.

Authors: 
Journal:  Blut       Date:  1985-03

3.  Effect of the choice of WHO International Reference Preparation for thromboplastin on International Normalised Ratios.

Authors:  L Poller; D A Taberner; J M Thomson; J Morris; R S Mibashan; N K Shinton
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

4.  Advances in Oral Coagulants.

Authors:  Eleanor S Pollak
Journal:  EJIFCC       Date:  2013-01-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.